Origen de la red de primer grado Zachary Dutton.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Zachary Dutton a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Pharmaceuticals: Major | Founder | |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Comptroller/Controller/Auditor | |
Curtana Pharmaceuticals, Inc.
Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
LoveMyDelta, Inc.
LoveMyDelta, Inc. Information Technology ServicesTechnology Services LoveMyDelta, Inc. provides technology services. The company is headquartered in Philadelphia, PA. | Information Technology Services | Director/Board Member | |
Fidia Farmaceutici SpA
Fidia Farmaceutici SpA Medical SpecialtiesHealth Technology Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy. | Medical Specialties | Corporate Officer/Principal | |
University of Padua | College/University | Doctorate Degree | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Investment Committee Member | |
Nemysis Ltd.
Nemysis Ltd. BiotechnologyHealth Technology Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
ExPharma Ltd.
ExPharma Ltd. BiotechnologyHealth Technology ExPharma Ltd. is a virtual healthcare company. It specializes in food supplements, foods for special medical purposes, medical devices, and diagnostics. The company was founded on September 4, 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Ajinomoto Cambrooke, Inc.
Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Pharmaceuticals: Other | Director/Board Member | |
Glycemicon AG
Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Santa Clara University | College/University | Masters Business Admin | |
AEOLUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Rouses Point Pharmaceuticals LLC
Rouses Point Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Rouses Point Pharmaceuticals LLC manufactures and distributes medicines. Its products include Propranolol ER family, Hydrocortisone Butyrate family, and Nitroglycerin Lingual Aerosol. The company was founded by Joseph J. Krivulka and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
West Virginia Wesleyan College | College/University | Undergraduate Degree | |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Pharmaceuticals: Major | Chief Executive Officer | |
Mylan Technologies, Inc.
Mylan Technologies, Inc. Containers/PackagingProcess Industries Mylan Technologies, Inc. designs, develops, and manufactures transdermal drug delivery systems, and associated materials and technologies. The company is headquartered in St. Albans, VT. | Containers/Packaging | President | |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Founder | |
University of California, Davis | College/University | Graduate Degree | |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Triax Pharmaceuticals LLC
Triax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Triax Pharmaceuticals LLC manufactures, distributes, and markets dermatological products. The company was founded by Leonard L. Mazur and Joseph J. Krivulka in November 2004 and is headquartered in Cranford, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
MIST Pharmaceuticals LLC
MIST Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology MIST Pharmaceuticals LLC provides therapeutic options for patients with cardiovascular and metabolic disease as well as acute and chronic pain. The private company is based in Cranford, NJ. The company was founded by Joseph J. Krivulka. | Pharmaceuticals: Major | Founder | |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ALEXANDRIA REAL ESTATE EQUITIES, INC. | Real Estate Investment Trusts | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 28 |
Reino Unido | 4 |
Italia | 3 |
Francia | 3 |
Canadá | 3 |
Sectorial
Health Technology | 28 |
Consumer Services | 5 |
Commercial Services | 4 |
Finance | 3 |
Technology Services | 2 |
Operativa
Director/Board Member | 20 |
Founder | 9 |
Chairman | 7 |
Chief Executive Officer | 6 |
Independent Dir/Board Member | 6 |
Las relaciones más conectadas
Insiders | |
---|---|
Joseph J. Krivulka | 17 |
Martin Simonetti | 13 |
Danilo Casadei-Massari | 11 |
Peter Moriarty | 2 |
- Bolsa de valores
- Insiders
- Zachary Dutton
- Conexiones Empresas